Gosselies, Belgium · Founded 2010 · Privately Held (backing)
Operator of a clinical-stage biopharmaceutical company intended to prevent and treat thrombotic and inflammatory diseases. Bioxodes is based in Gosselies, Belgium and was founded in 2010. Its last reported valuation was $116 million in Feb 2025. It has raised $39.1 million.
Last reported valuation
$115.5M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
—
Team — not yet on record
No current team members for Bioxodes are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Bioxodes with a free account
·The complete investor list: 12 names
·Watch Bioxodes: the Monday email on marks, rounds and moves
